™All Companies & Capital
-
Moonshot Executives Reported in Settlement Talks With Shareholder, Claim Tops $700 Million
Why it mattersMoonshot confidentially filed for a Hong Kong IPO in September, and this is an unresolved shareholder dispute ahead of the listing.
-
Amazon in Talks to Buy AI Startup Decart in Deal Valued Around $7 Billion
Why it mattersA deal at that price would top Decart's nearly $4 billion valuation from May, and its cross-chip software would join the AWS system built around Amazon's own chips.
-
Cloudflare Acquires Deno: Deploy Shuts Down in Six Months
Why it mattersDeno had raised $26 million in total, and the shutdown of its hosting service gives existing users a six-month migration window, with Cloudflare Workers as the destination.
-
Google's $15 Billion India AI Data Center Sparks Backlash; Company Responds to Water and Power Fears
Why it mattersGoogle's biggest overseas AI infrastructure project is facing organized local opposition for the first time, putting the environmental cost of AI buildouts on the table.
-
Sesterce Plans $11B AI Data Center Investment in Finland
Why it mattersSesterce plans to spend more than €10 billion (about $11.2 billion) on an AI data center in Finland: a 200MW first phase starting in 2026, with an anchor customer secured.
-
Nuvacore Seeks Raise at About $2.5B Valuation, Six Months After Founding
Why it mattersSemiconductor startups raised $10.7B in the first five months of 2026, nearing all of 2025's $12.2B.
-
US Government, Meta and Google Join Biohub's $1.8B Open Dataset Effort for Biology AI
Why it mattersWith the DOE, NIH, Meta and Google DeepMind on board, the Virtual Biology Initiative grows from April's $500 million to $1.8 billion; the first datasets are due in about a year, with predictive cell models targeted within five years.
-
Isomorphic Labs in Talks at a $40–50B Valuation; No Drug Yet in Human Trials
Why it mattersIsomorphic is in talks at a valuation of at least $40 billion and up to $50 billion, five months after a $2.1 billion Series B; none of its drugs has entered human trials.
-
Sequoia Leads $60M Series B for Robot-Data Startup Mecka AI
Why it mattersThe $60 million round is led by Sequoia with Nvidia and Microsoft's M12 participating, at a previously reported ~$500 million valuation; Mecka pays people to record everyday tasks to train humanoid robots.
-
Arena Raises $200M Series B at $3.1B Valuation
Why it mattersArena's annualized revenue has passed $100 million and it tracks more than 1,000 open and closed models; alongside the round it launched the Alignment Index to measure how well AI aligns with human values.
